Distance to Health Care Facilities, Lifestyle Risk Factors, and Stage at Diagnosis in relation to Geographic Pattern of Esophageal Cancer in Tanzania, 2006-2016.
Journal
Journal of cancer epidemiology
ISSN: 1687-8558
Titre abrégé: J Cancer Epidemiol
Pays: Egypt
ID NLM: 101519967
Informations de publication
Date de publication:
2022
2022
Historique:
received:
27
02
2022
revised:
15
07
2022
accepted:
05
08
2022
entrez:
1
9
2022
pubmed:
2
9
2022
medline:
2
9
2022
Statut:
epublish
Résumé
Esophageal cancer is an aggressive, often deadly disease globally that represents a significant health problem in Tanzania. The WHO reported 604,100 new esophageal cancer cases worldwide during 2020 and 544,076 deaths (Sung, 2021; World Health Organization, 2020). In Eastern Africa, 16,137 cases and 15,188 deaths were related to this disease in 2020. Esophageal cancer is associated with various etiologic risk factors, and access to the disease treatment is a major barrier to survival. This study examined associations between the prevalence of four geographically stratified, population-level, etiologic risk factors (tobacco use, unprotected water use, solid fuel source use, and poverty), as well as two access-to-care predictors (persons per hospital and distance from residence to where esophageal cancer treatment occurs). Regional- and coarser-scale zonal incidence rates were calculated for 2006 through 2016 and evaluated for geographic differences in relation to risk factors and access to care predictors using Poisson regression. Differences in the geographic distribution of esophageal cancer were observed. Distance from the region of residence to the treatment center (Ocean Road Cancer Institute) was statistically associated with the geographic pattern of esophageal cancer incidence. Further research into etiologic risk factors, dietary practices, and nutrition is needed to better understand the associations with esophageal cancer in Tanzania and other parts of Eastern Africa.
Identifiants
pubmed: 36046119
doi: 10.1155/2022/7873588
pmc: PMC9423990
doi:
Types de publication
Journal Article
Langues
eng
Pagination
7873588Informations de copyright
Copyright © 2022 Richard Watkins et al.
Déclaration de conflit d'intérêts
The authors declare that they have no conflicts of interest.
Références
Nat Genet. 2021 Nov;53(11):1553-1563
pubmed: 34663923
Nat Rev Cancer. 2022 May;22(5):253-254
pubmed: 35246668
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
J Gastrointest Cancer. 2013 Jun;44(2):143-51
pubmed: 23435833
Br J Cancer. 2010 Sep 28;103(7):1025-33
pubmed: 20808308
J Glob Oncol. 2019 Jul;5:JGO1800052
pubmed: 31343933
Cancer Epidemiol Biomarkers Prev. 2021 Feb;30(2):305-316
pubmed: 33144280
Cancer Med. 2022 Jun 30;:
pubmed: 35770745
World J Gastrointest Oncol. 2016 Mar 15;8(3):314-20
pubmed: 26989467
Curr Opin Gastroenterol. 2022 Jul 1;38(4):423-427
pubmed: 35762703
Science. 2011 Jun 10;332(6035):1322-6
pubmed: 21659605
Best Pract Res Clin Gastroenterol. 2017 Oct;31(5):509-517
pubmed: 29195670
Endosc Int Open. 2021 Nov 12;9(11):E1827-E1836
pubmed: 34790551
Int J Cancer. 2017 Jan 15;140(2):259-271
pubmed: 27466161
Afr Health Sci. 2005 Jun;5(2):157-63
pubmed: 16006224
Diabetes Care. 2021 Feb;44(2):340-349
pubmed: 33334808
J Epidemiol. 2005 Jun;15 Suppl 2:S212-9
pubmed: 16127236
ISRN Oncol. 2013 Dec 29;2013:503249
pubmed: 24490085
Cancers (Basel). 2022 Jan 22;14(3):
pubmed: 35158822
J Gastroenterol Hepatol. 2022 Aug;37(8):1507-1516
pubmed: 35614860
Int J Cancer. 2022 Jun 11;:
pubmed: 35689438
Am J Gastroenterol. 2021 Sep 1;116(9):1844-1852
pubmed: 34240714
Cleve Clin J Med. 2022 May 2;89(5):269-279
pubmed: 35500930
Int J Cancer. 2019 Feb 1;144(3):459-469
pubmed: 30117158
Cancer Epidemiol Biomarkers Prev. 2021 Feb;30(2):248-251
pubmed: 33547145
Semin Oncol. 1999 Oct;26(5 Suppl 15):2-8
pubmed: 10566604